MedTrace Logo

Failure Rate of GLyburide And Metformin Among Gestational Diabetics

NCT03078725 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2018-05-04

No results posted yet for this study

Summary

A pragmatic, comparative effectiveness trial of glyburide versus metformin.

Conditions

  • Gestational Diabetes Mellitus, Class A2

Interventions

DRUG

Glyburide

oral hypoglycemic agent

DRUG

Metformin

oral hypoglycemic agent

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2018-03-10
Completion
2018-05-10
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078725 on ClinicalTrials.gov